Cargando…
Evaluation of Dosing Time-Related Anti-Hypertensive Efficacy of Valsartan in Patients with Type 2 Diabetes
The aim of this study was to evaluate which administration timing of valsartan provides satisfactory blood pressure (BP) control, once daily in the morning, once daily in the evening, or twice daily in total 160 mg. Hypertensive patients with mild-to-moderate diabetic nephropathy were enrolled, but...
Autores principales: | Suzuki, Katsunori, Aizawa, Yoshifusa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673599/ https://www.ncbi.nlm.nih.gov/pubmed/21166600 http://dx.doi.org/10.3109/10641963.2010.503306 |
Ejemplares similares
-
Improved Early-Phase Insulin Response after Candesartan Treatment in Hypertensive Patients with Impaired Glucose Tolerance
por: Suzuki, Katsunori, et al.
Publicado: (2008) -
Investigation of the introduction of three times daily injections of Insulin Lispro Mixture-50 on an outpatient basis: Therapeutic effects of 12 months’ treatment with and without concomitant sulfonylurea
por: Suzuki, Katsunori, et al.
Publicado: (2012) -
Optimal timing for antihypertensive dosing: focus on valsartan
por: Hermida, Ramón C, et al.
Publicado: (2007) -
Pharmaceutical Composition of Valsartan: β-Cyclodextrin: Physico–Chemical and Characterization Anti-Hypertensive Evaluation
por: Eduardo de Matos Jensen, Carlos, et al.
Publicado: (2010) -
Efficacy and Safety of Valsartan or Chlorthalidone vs. Combined
Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The
VACLOR Study
por: Manzur, Fernando, et al.
Publicado: (2018)